Answers are grounded in this paper and cite their sources.
This research demonstrates the synthesis of new spirocyclic inhibitors for HIV-1 using cycloaddition of benzo[d]thiazoles and DACs, implying potential therapeutic applications.
The reaction of benzo[d]thiazoles with imidazol-4-one activated donor-acceptor cyclopropanes (DACs) represents a practicable cycloaddition resulting in new spirocyclic compounds. DACs react with a variety of benzo[d]thiazoles with electon-donating or electron-withdrawing...
No takes yet. Share an insight, caveat, or question.
Ikonnikova et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: